244 related articles for article (PubMed ID: 28598414)
1. Structure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targets.
Lu X; Nowicka U; Sridharan V; Liu F; Randles L; Hymel D; Dyba M; Tarasov SG; Tarasova NI; Zhao XZ; Hamazaki J; Murata S; Burke TR; Walters KJ
Nat Commun; 2017 Jun; 8():15540. PubMed ID: 28598414
[TBL] [Abstract][Full Text] [Related]
2. Impact of Losing hRpn13 Pru or UCHL5 on Proteasome Clearance of Ubiquitinated Proteins and RA190 Cytotoxicity.
Osei-Amponsa V; Sridharan V; Tandon M; Evans CN; Klarmann K; Cheng KT; Lack J; Chari R; Walters KJ
Mol Cell Biol; 2020 Aug; 40(18):. PubMed ID: 32631902
[TBL] [Abstract][Full Text] [Related]
3. The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression.
Randles L; Anchoori RK; Roden RB; Walters KJ
J Biol Chem; 2016 Apr; 291(16):8773-83. PubMed ID: 26907685
[TBL] [Abstract][Full Text] [Related]
4. A novel proteasome interacting protein recruits the deubiquitinating enzyme UCH37 to 26S proteasomes.
Hamazaki J; Iemura S; Natsume T; Yashiroda H; Tanaka K; Murata S
EMBO J; 2006 Oct; 25(19):4524-36. PubMed ID: 16990800
[TBL] [Abstract][Full Text] [Related]
5. A High Affinity hRpn2-Derived Peptide That Displaces Human Rpn13 from Proteasome in 293T Cells.
Lu X; Liu F; Durham SE; Tarasov SG; Walters KJ
PLoS One; 2015; 10(10):e0140518. PubMed ID: 26466095
[TBL] [Abstract][Full Text] [Related]
6. Structure of proteasome ubiquitin receptor hRpn13 and its activation by the scaffolding protein hRpn2.
Chen X; Lee BH; Finley D; Walters KJ
Mol Cell; 2010 May; 38(3):404-15. PubMed ID: 20471946
[TBL] [Abstract][Full Text] [Related]
7. hRpn13/ADRM1/GP110 is a novel proteasome subunit that binds the deubiquitinating enzyme, UCH37.
Qiu XB; Ouyang SY; Li CJ; Miao S; Wang L; Goldberg AL
EMBO J; 2006 Dec; 25(24):5742-53. PubMed ID: 17139257
[TBL] [Abstract][Full Text] [Related]
8. Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1.
Yao T; Song L; Xu W; DeMartino GN; Florens L; Swanson SK; Washburn MP; Conaway RC; Conaway JW; Cohen RE
Nat Cell Biol; 2006 Sep; 8(9):994-1002. PubMed ID: 16906146
[TBL] [Abstract][Full Text] [Related]
9. An Extended Conformation for K48 Ubiquitin Chains Revealed by the hRpn2:Rpn13:K48-Diubiquitin Structure.
Lu X; Ebelle DL; Matsuo H; Walters KJ
Structure; 2020 May; 28(5):495-506.e3. PubMed ID: 32160516
[TBL] [Abstract][Full Text] [Related]
10. Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism.
VanderLinden RT; Hemmis CW; Yao T; Robinson H; Hill CP
J Biol Chem; 2017 Jun; 292(23):9493-9504. PubMed ID: 28442575
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of Tyr-950 in the proteasome scaffolding protein RPN2 modulates its interaction with the ubiquitin receptor RPN13.
Hemmis CW; Heard SC; Hill CP
J Biol Chem; 2019 Jun; 294(25):9659-9665. PubMed ID: 31064842
[TBL] [Abstract][Full Text] [Related]
12. Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling.
Soong RS; Anchoori RK; Roden RBS; Cho RL; Chen YC; Tseng SC; Huang YL; Liao PC; Shyu YC
BMC Cancer; 2020 May; 20(1):386. PubMed ID: 32375699
[TBL] [Abstract][Full Text] [Related]
13. A structure-based designed small molecule depletes hRpn13
Lu X; Chandravanshi M; Sabbasani VR; Gaikwad S; Hughitt VK; Gyabaah-Kessie N; Scroggins BT; Das S; Myint W; Clapp ME; Schwieters CD; Dyba MA; Bolhuis DL; Koscielniak JW; Andresson T; Emanuele MJ; Brown NG; Matsuo H; Chari R; Citrin DE; Mock BA; Swenson RE; Walters KJ
Nat Commun; 2024 Mar; 15(1):2485. PubMed ID: 38509117
[TBL] [Abstract][Full Text] [Related]
14. Early and consistent overexpression of ADRM1 in ovarian high-grade serous carcinoma.
Jiang RT; Yemelyanova A; Xing D; Anchoori RK; Hamazaki J; Murata S; Seidman JD; Wang TL; Roden RBS
J Ovarian Res; 2017 Aug; 10(1):53. PubMed ID: 28784174
[TBL] [Abstract][Full Text] [Related]
15. Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms between Substrate Receptors and Shuttle Factors of the Proteasome.
Chen X; Randles L; Shi K; Tarasov SG; Aihara H; Walters KJ
Structure; 2016 Aug; 24(8):1257-1270. PubMed ID: 27396824
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties.
Anchoori RK; Tan M; Tseng SH; Peng S; Soong RS; Algethami A; Foran P; Das S; Wang C; Wang TL; Liang H; Hung CF; Roden RBS
PLoS One; 2020; 15(1):e0227727. PubMed ID: 31940398
[TBL] [Abstract][Full Text] [Related]
17. A fluorescence polarization-based competition assay for measuring interactions between unlabeled ubiquitin chains and UCH37•RPN13.
Du J; Strieter ER
Anal Biochem; 2018 Jun; 550():84-89. PubMed ID: 29698671
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
Vander Linden RT; Hemmis CW; Schmitt B; Ndoja A; Whitby FG; Robinson H; Cohen RE; Yao T; Hill CP
Mol Cell; 2015 Mar; 57(5):901-911. PubMed ID: 25702872
[TBL] [Abstract][Full Text] [Related]
19. Proteasome-Bound UCH37/UCHL5 Debranches Ubiquitin Chains to Promote Degradation.
Deol KK; Crowe SO; Du J; Bisbee HA; Guenette RG; Strieter ER
Mol Cell; 2020 Dec; 80(5):796-809.e9. PubMed ID: 33156996
[TBL] [Abstract][Full Text] [Related]
20. Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma.
Song Y; Ray A; Li S; Das DS; Tai YT; Carrasco RD; Chauhan D; Anderson KC
Leukemia; 2016 Sep; 30(9):1877-86. PubMed ID: 27118409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
